img

Global Therapeutic Enzyme Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Therapeutic Enzyme Drugs Market Insights, Forecast to 2034

Therapeutic Enzyme Drugs are medications that utilize enzymes to treat various medical conditions. These drugs are designed to replace deficient or malfunctioning enzymes in the body or modify biochemical processes. They can target genetic disorders, enzyme deficiencies, and other diseases by restoring normal metabolic pathways. Therapeutic enzyme drugs can be administered through injections or other delivery methods and play a vital role in managing conditions that arise from enzyme dysfunction.
Market Analysis and InsightsGlobal Therapeutic Enzyme Drugs Market
Global Therapeutic Enzyme Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Therapeutic Enzyme Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Therapeutic Enzyme Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Therapeutic Enzyme Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care
Segment by Type
Injectable
Oral
Topical

Segment by Application


Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Therapeutic Enzyme Drugs introduction, etc. Therapeutic Enzyme Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Therapeutic Enzyme Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injectable
1.2.3 Oral
1.2.4 Topical
1.3 Market by Application
1.3.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Gaucher Disease
1.3.3 MPS Disease
1.3.4 Gastrointestinal Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Enzyme Drugs Market Perspective (2018-2029)
2.2 Global Therapeutic Enzyme Drugs Growth Trends by Region
2.2.1 Therapeutic Enzyme Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Enzyme Drugs Historic Market Size by Region (2018-2024)
2.2.3 Therapeutic Enzyme Drugs Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Enzyme Drugs Market Dynamics
2.3.1 Therapeutic Enzyme Drugs Industry Trends
2.3.2 Therapeutic Enzyme Drugs Market Drivers
2.3.3 Therapeutic Enzyme Drugs Market Challenges
2.3.4 Therapeutic Enzyme Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Therapeutic Enzyme Drugs by Players
3.1.1 Global Therapeutic Enzyme Drugs Revenue by Players (2018-2024)
3.1.2 Global Therapeutic Enzyme Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Therapeutic Enzyme Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Therapeutic Enzyme Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Therapeutic Enzyme Drugs Market Concentration Ratio
3.4.1 Global Therapeutic Enzyme Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Enzyme Drugs Revenue in 2022
3.5 Global Key Players of Therapeutic Enzyme Drugs Head office and Area Served
3.6 Global Key Players of Therapeutic Enzyme Drugs, Product and Application
3.7 Global Key Players of Therapeutic Enzyme Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Enzyme Drugs Breakdown Data by Type
4.1 Global Therapeutic Enzyme Drugs Historic Market Size by Type (2018-2024)
4.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2024-2029)
5 Therapeutic Enzyme Drugs Breakdown Data by Application
5.1 Global Therapeutic Enzyme Drugs Historic Market Size by Application (2018-2024)
5.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Enzyme Drugs Market Size (2018-2029)
6.2 North America Therapeutic Enzyme Drugs Market Size by Type
6.2.1 North America Therapeutic Enzyme Drugs Market Size by Type (2018-2024)
6.2.2 North America Therapeutic Enzyme Drugs Market Size by Type (2024-2029)
6.2.3 North America Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
6.3 North America Therapeutic Enzyme Drugs Market Size by Application
6.3.1 North America Therapeutic Enzyme Drugs Market Size by Application (2018-2024)
6.3.2 North America Therapeutic Enzyme Drugs Market Size by Application (2024-2029)
6.3.3 North America Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
6.4 North America Therapeutic Enzyme Drugs Market Size by Country
6.4.1 North America Therapeutic Enzyme Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Therapeutic Enzyme Drugs Market Size by Country (2018-2024)
6.4.3 North America Therapeutic Enzyme Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Therapeutic Enzyme Drugs Market Size (2018-2029)
7.2 Europe Therapeutic Enzyme Drugs Market Size by Type
7.2.1 Europe Therapeutic Enzyme Drugs Market Size by Type (2018-2024)
7.2.2 Europe Therapeutic Enzyme Drugs Market Size by Type (2024-2029)
7.2.3 Europe Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
7.3 Europe Therapeutic Enzyme Drugs Market Size by Application
7.3.1 Europe Therapeutic Enzyme Drugs Market Size by Application (2018-2024)
7.3.2 Europe Therapeutic Enzyme Drugs Market Size by Application (2024-2029)
7.3.3 Europe Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
7.4 Europe Therapeutic Enzyme Drugs Market Size by Country
7.4.1 Europe Therapeutic Enzyme Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Therapeutic Enzyme Drugs Market Size by Country (2018-2024)
7.4.3 Europe Therapeutic Enzyme Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Therapeutic Enzyme Drugs Market Size (2018-2029)
8.2 China Therapeutic Enzyme Drugs Market Size by Type
8.2.1 China Therapeutic Enzyme Drugs Market Size by Type (2018-2024)
8.2.2 China Therapeutic Enzyme Drugs Market Size by Type (2024-2029)
8.2.3 China Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
8.3 China Therapeutic Enzyme Drugs Market Size by Application
8.3.1 China Therapeutic Enzyme Drugs Market Size by Application (2018-2024)
8.3.2 China Therapeutic Enzyme Drugs Market Size by Application (2024-2029)
8.3.3 China Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Therapeutic Enzyme Drugs Market Size (2018-2029)
9.2 Asia Therapeutic Enzyme Drugs Market Size by Type
9.2.1 Asia Therapeutic Enzyme Drugs Market Size by Type (2018-2024)
9.2.2 Asia Therapeutic Enzyme Drugs Market Size by Type (2024-2029)
9.2.3 Asia Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
9.3 Asia Therapeutic Enzyme Drugs Market Size by Application
9.3.1 Asia Therapeutic Enzyme Drugs Market Size by Application (2018-2024)
9.3.2 Asia Therapeutic Enzyme Drugs Market Size by Application (2024-2029)
9.3.3 Asia Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
9.4 Asia Therapeutic Enzyme Drugs Market Size by Region
9.4.1 Asia Therapeutic Enzyme Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Therapeutic Enzyme Drugs Market Size by Region (2018-2024)
9.4.3 Asia Therapeutic Enzyme Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Therapeutic Enzyme Drugs Introduction
11.1.4 Sanofi Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 BioMarin
11.2.1 BioMarin Company Details
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Therapeutic Enzyme Drugs Introduction
11.2.4 BioMarin Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.2.5 BioMarin Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Therapeutic Enzyme Drugs Introduction
11.3.4 AbbVie Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.3.5 AbbVie Recent Developments
11.4 Shire
11.4.1 Shire Company Details
11.4.2 Shire Business Overview
11.4.3 Shire Therapeutic Enzyme Drugs Introduction
11.4.4 Shire Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.4.5 Shire Recent Developments
11.5 Alexion
11.5.1 Alexion Company Details
11.5.2 Alexion Business Overview
11.5.3 Alexion Therapeutic Enzyme Drugs Introduction
11.5.4 Alexion Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.5.5 Alexion Recent Developments
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Therapeutic Enzyme Drugs Introduction
11.6.4 Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.6.5 Horizon Pharma Recent Developments
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Therapeutic Enzyme Drugs Introduction
11.7.4 Allergan Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.7.5 Allergan Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Therapeutic Enzyme Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.8.5 Johnson & Johnson Recent Developments
11.9 Recordati Rare Diseases
11.9.1 Recordati Rare Diseases Company Details
11.9.2 Recordati Rare Diseases Business Overview
11.9.3 Recordati Rare Diseases Therapeutic Enzyme Drugs Introduction
11.9.4 Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.9.5 Recordati Rare Diseases Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Therapeutic Enzyme Drugs Introduction
11.10.4 Pfizer Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.10.5 Pfizer Recent Developments
11.11 Vivus
11.11.1 Vivus Company Details
11.11.2 Vivus Business Overview
11.11.3 Vivus Therapeutic Enzyme Drugs Introduction
11.11.4 Vivus Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.11.5 Vivus Recent Developments
11.12 Digestive Care
11.12.1 Digestive Care Company Details
11.12.2 Digestive Care Business Overview
11.12.3 Digestive Care Therapeutic Enzyme Drugs Introduction
11.12.4 Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2018-2024)
11.12.5 Digestive Care Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Injectable
Table 3. Key Players of Oral
Table 4. Key Players of Topical
Table 5. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Therapeutic Enzyme Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Therapeutic Enzyme Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Therapeutic Enzyme Drugs Market Share by Region (2018-2024)
Table 9. Global Therapeutic Enzyme Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Therapeutic Enzyme Drugs Market Share by Region (2024-2029)
Table 11. Therapeutic Enzyme Drugs Market Trends
Table 12. Therapeutic Enzyme Drugs Market Drivers
Table 13. Therapeutic Enzyme Drugs Market Challenges
Table 14. Therapeutic Enzyme Drugs Market Restraints
Table 15. Global Therapeutic Enzyme Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Therapeutic Enzyme Drugs Revenue Share by Players (2018-2024)
Table 17. Global Top Therapeutic Enzyme Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2022)
Table 18. Global Therapeutic Enzyme Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Therapeutic Enzyme Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Therapeutic Enzyme Drugs, Headquarters and Area Served
Table 21. Global Key Players of Therapeutic Enzyme Drugs, Product and Application
Table 22. Global Key Players of Therapeutic Enzyme Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Therapeutic Enzyme Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Therapeutic Enzyme Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Therapeutic Enzyme Drugs Revenue Share by Application (2018-2024)
Table 30. Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Therapeutic Enzyme Drugs Revenue Share by Application (2024-2029)
Table 32. North America Therapeutic Enzyme Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Therapeutic Enzyme Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Therapeutic Enzyme Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Therapeutic Enzyme Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Therapeutic Enzyme Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Therapeutic Enzyme Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Therapeutic Enzyme Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Therapeutic Enzyme Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Therapeutic Enzyme Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Therapeutic Enzyme Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Therapeutic Enzyme Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Therapeutic Enzyme Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Therapeutic Enzyme Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Therapeutic Enzyme Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Therapeutic Enzyme Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Therapeutic Enzyme Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Therapeutic Enzyme Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Therapeutic Enzyme Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Therapeutic Enzyme Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Therapeutic Enzyme Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Therapeutic Enzyme Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Therapeutic Enzyme Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Therapeutic Enzyme Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Therapeutic Enzyme Drugs Product
Table 67. Sanofi Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 68. Sanofi Recent Developments
Table 69. BioMarin Company Details
Table 70. BioMarin Business Overview
Table 71. BioMarin Therapeutic Enzyme Drugs Product
Table 72. BioMarin Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 73. BioMarin Recent Developments
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Therapeutic Enzyme Drugs Product
Table 77. AbbVie Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 78. AbbVie Recent Developments
Table 79. Shire Company Details
Table 80. Shire Business Overview
Table 81. Shire Therapeutic Enzyme Drugs Product
Table 82. Shire Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 83. Shire Recent Developments
Table 84. Alexion Company Details
Table 85. Alexion Business Overview
Table 86. Alexion Therapeutic Enzyme Drugs Product
Table 87. Alexion Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 88. Alexion Recent Developments
Table 89. Horizon Pharma Company Details
Table 90. Horizon Pharma Business Overview
Table 91. Horizon Pharma Therapeutic Enzyme Drugs Product
Table 92. Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 93. Horizon Pharma Recent Developments
Table 94. Allergan Company Details
Table 95. Allergan Business Overview
Table 96. Allergan Therapeutic Enzyme Drugs Product
Table 97. Allergan Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 98. Allergan Recent Developments
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Therapeutic Enzyme Drugs Product
Table 102. Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 103. Johnson & Johnson Recent Developments
Table 104. Recordati Rare Diseases Company Details
Table 105. Recordati Rare Diseases Business Overview
Table 106. Recordati Rare Diseases Therapeutic Enzyme Drugs Product
Table 107. Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 108. Recordati Rare Diseases Recent Developments
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Therapeutic Enzyme Drugs Product
Table 112. Pfizer Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 113. Pfizer Recent Developments
Table 114. Vivus Company Details
Table 115. Vivus Business Overview
Table 116. Vivus Therapeutic Enzyme Drugs Product
Table 117. Vivus Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 118. Vivus Recent Developments
Table 119. Digestive Care Company Details
Table 120. Digestive Care Business Overview
Table 121. Digestive Care Therapeutic Enzyme Drugs Product
Table 122. Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2018-2024) & (US$ Million)
Table 123. Digestive Care Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Therapeutic Enzyme Drugs Market Share by Type: 2022 VS 2029
Figure 3. Injectable Features
Figure 4. Oral Features
Figure 5. Topical Features
Figure 6. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Therapeutic Enzyme Drugs Market Share by Application: 2022 VS 2029
Figure 8. Gaucher Disease Case Studies
Figure 9. MPS Disease Case Studies
Figure 10. Gastrointestinal Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. Therapeutic Enzyme Drugs Report Years Considered
Figure 13. Global Therapeutic Enzyme Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Therapeutic Enzyme Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Therapeutic Enzyme Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Therapeutic Enzyme Drugs Market Share by Players in 2022
Figure 17. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Enzyme Drugs Revenue in 2022
Figure 19. North America Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
Figure 21. North America Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
Figure 22. North America Therapeutic Enzyme Drugs Market Share by Country (2018-2029)
Figure 23. United States Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Therapeutic Enzyme Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
Figure 27. Europe Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
Figure 28. Europe Therapeutic Enzyme Drugs Market Share by Country (2018-2029)
Figure 29. Germany Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Therapeutic Enzyme Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
Figure 37. China Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
Figure 38. Asia Therapeutic Enzyme Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
Figure 40. Asia Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
Figure 41. Asia Therapeutic Enzyme Drugs Market Share by Region (2018-2029)
Figure 42. Japan Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Therapeutic Enzyme Drugs Market Share by Country (2018-2029)
Figure 52. Brazil Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 59. BioMarin Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 60. AbbVie Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 61. Shire Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 62. Alexion Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 63. Horizon Pharma Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 64. Allergan Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 65. Johnson & Johnson Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 66. Recordati Rare Diseases Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 67. Pfizer Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 68. Vivus Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 69. Digestive Care Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries